Get the Stockscreener App
2.82
6.31%
-0.19
After Hours:
2.85
0.03
+1.06%
Jaguar Health Inc stock is traded at $2.82, with a volume of 237.75K.
It is down -6.31% in the last 24 hours and down -80.35% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
See More
Previous Close:
$3.01
Open:
$3.19
24h Volume:
237.75K
Relative Volume:
7.53
Market Cap:
$1.05M
Revenue:
$11.51M
Net Income/Loss:
$-54.00M
P/E Ratio:
-0.00396
EPS:
-711.8194
Net Cash Flow:
$-23.73M
1W Performance:
-64.19%
1M Performance:
-80.35%
6M Performance:
-94.79%
1Y Performance:
-99.19%
1-Day Range:
$2.53
$3.19
1-Week Range:
$2.53
$7.9976
52-Week Range:
$2.53
$359.98
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
2.82 | 1.12M | 11.51M | -54.00M | -23.73M | -711.82 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
Number of shareholders of Jaguar Health, Inc. – NASDAQ:JAGX - TradingView
Jaguar Health discusses breakthrough therapy path for MVID treatment - Investing.com
Drug for lethal ultrarare childhood disease enters FDA breakthrough talks - Stock Titan
Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Yahoo Finance
Jaguar Health, Inc. Files Form 8-K with SEC – Company Information and Event Disclosure (May 2026) - Minichart
Jaguar Health Boosts Public Float to Regain Nasdaq Compliance - TipRanks
Jaguar Health | 8-K: Current report - Moomoo
Jaguar Health (NASDAQ: JAGX) lifts public float above Nasdaq minimum after split - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Jaguar Health, Inc. Trade Ideas — GETTEX:1JA1 - TradingView
Jaguar Health, Inc. Files Form 8-K With SEC for May 2026 – Company Information, Nasdaq Listing, and Compliance Update - Minichart
Jaguar Health (JAGX) Set to Launch Neonorm Dog for Pet Wellness - GuruFocus
Jaguar Health to launch Neonorm Dog digestive health product By Investing.com - Investing.com Australia
Jaguar Health to launch Neonorm Dog digestive health product - Investing.com
Jaguar pushes Neonorm into dogs with plant-based, nonprescription gut aid - Stock Titan
Jaguar Animal Health Faces New Nasdaq Compliance Deficiency - TipRanks
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health - ACCESS Newswire
Jaguar Health Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Jaguar Health (NASDAQ: JAGX) risks delisting after reverse split cuts public float - Stock Titan
MSN Money - MSN
Jaguar Health, Inc. Revenue Breakdown – MUN:1JA1 - TradingView
Working capital per share of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Cash from investing activities of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Jaguar Health, Inc. Cash Flow – MUN:1JA1 - TradingView
EBITDA of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Jaguar Health, Inc. Income Statement – MUN:1JA1 - TradingView
Inventory turnover of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Cost of goods sold of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Return on equity % of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Long term debt to total equity ratio of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Total liabilities & shareholders' equities of Jaguar Health, Inc. – MUN:1JA1 - TradingView
Total liabilities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Net debt of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Cash from financing activities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Tangible book value per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Jaguar Health, Inc. Dividends – FWB:1JA1 - TradingView
Price to cash flow ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Jaguar Health, Inc. Earnings and Revenue – FWB:1JA1 - TradingView
Enterprise value to EBITDA ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Long term debt to total equity ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Long term debt to total assets ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Quick ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Total debt of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Enterprise value of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Total liabilities & shareholders' equities of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Asset turnover of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Inventory turnover of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Debt to assets ratio of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Free cash flow per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Operating cash flow per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
CapEx per share of Jaguar Health, Inc. – FWB:1JA1 - TradingView
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):